Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
Company Contact | |
Address: | Bay 1, 4600-5 Street NE CALGARY AB T2E 7C3 |
Tel: | 1-415-5728152 |
Website: | https://www.nanalysis.com/nsci-overview |
IR: | See website |
Key People | ||
Sean Krakiwsky Chairman of the Board, President, Chief Executive Officer | Randall Mcrae Chief Financial Officer | Julien Mueller Chief Technology Officer |
Heather Phillips Vice President - Operations | Susanne Riegel Vice President Marketing and Product Manager | Neal Gallagher Vice President - Product Development |
Kham Lin Managing Director, Security Business | Bruce Lix Director of Business Development | Greg Mcfeetors Head of Manufacturing |
Business Overview |
Nanalysis Scientific Corp. is a Canada-based patent-protected technology company that develops, manufactures and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. The Company operates through four segments: Nanalysis, RS2D, K'Prime and Corporate. The Company's subsidiaries include Nanalysis Corp., Nanalysis GmbH, RS2D S.A.S., One Moon Scientific (OMS), K'(Prime) Technologies Inc., KPrime Group USA, KPrime Technologies, Quad Systems AG and Quad Systems Ltd. RS2D S.A.S. is a technology company that is specialized in the designing of compact, electronics components for a range of precision analytical MR instruments, including both NMR and magnetic resonance imaging (MRI). OMS is a software company, which is specialized in a suite of software tools to streamline and automate magnetic resonance data analysis and management. |
Financial Overview |
For the nine months ended 30 September 2023, Nanalysis Scientific Corp revenues increased 6% to C$18.7M. Net loss increased from C$6.6M to C$14.1M. Revenues reflect K Prime segment increase of 51% to C$7.8M, Canada segment increase from C$3.7M to C$7.6M, Europe (Region) segment remaining flat at C$2.4M. Higher net loss reflects K Prime segment loss totaling C$1.3M vs. income of C$552K, Nanalysis segment loss increase of 16% to C$1.2M. |
Employees: | 249 as of Dec 31, 2022 |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $48.53M as of Sep 30, 2023 |
Annual revenue (TTM): | $25.87M as of Sep 30, 2023 |
EBITDA (TTM): | -$10.91M as of Sep 30, 2023 |
Net annual income (TTM): | -$17.37M as of Sep 30, 2023 |
Free cash flow (TTM): | -$18.29M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $16.85M as of Sep 30, 2023 |
Shares outstanding: | 111,721,681 as of Mar 27, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |